Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial-Reference-Cited by-同舟云学术

Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial

Published:2021-03-10 Issue:5 Volume:23 Page:826-834
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Tromp Jasper¹²³,Ponikowski Piotr⁴,Salsali Afshin⁵⁶,Angermann Christiane E.⁷,Biegus Jan⁴,Blatchford Jon⁸,Collins Sean P.⁹,Ferreira João Pedro¹⁰,Grauer Claudia⁸,Kosiborod Mikhail¹¹¹²,Nassif Michael E.¹¹,Psotka Mitchell A.¹³,Brueckmann Martina⁸¹⁴,Teerlink John R.¹⁵,Voors Adriaan A.¹

Affiliation:

1. Department of Cardiology University of Groningen, University Medical Center Groningen Groningen The Netherlands

2. Duke‐NUS Medical School Singapore

3. National Heart Centre Singapore Singapore

4. Department of Heart Diseases Medical University Wroclaw Poland

5. Boehringer Ingelheim Pharmaceuticals Ridgefield CT USA

6. Faculty of Medicine Rutgers University New Brunswick NJ USA

7. Comprehensive Heart Failure Center University and University Hospital, Würzburg, University Hospital Würzburg Würzburg Germany

8. Boehringer Ingelheim International GmbH Ingelheim Germany

9. Department of Emergency Medicine Vanderbilt University Medical Center Nashville TN USA

10. Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, CHRU de Nancy, F‐CRIN INI‐CRCT Nancy France

11. Saint Luke's Mid America Heart Institute and the University of Missouri Kansas City MO USA

12. The George Institute for Global Health and the University of New South Wales Sydney NSW Australia

13. Inova Heart and Vascular Institute Falls Church VA USA

14. Faculty of Medicine Mannheim University of Heidelberg Mannheim Germany

15. Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine University of California, San Francisco San Francisco CA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2137

Reference49 articles.

1. Heart failure around the world

2. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study

3. Forecasting the Impact of Heart Failure in the United States

4. Why do drugs for acute heart failure fail?

5. Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review and adaptation of European Federation of Internal Medicine clinical guidelines on acute heart failure;Russian Journal of Cardiology;2024-08-27

2. Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial;European Journal of Heart Failure;2024-07-30

3. Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post‐hoc analysis from EMPULSE;European Journal of Heart Failure;2024-07-09

4. Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation;Circulation: Cardiovascular Quality and Outcomes;2024-07

5. Use and Intensification of Oral Guideline-Directed Medical Therapy in Hospitalized Patients With Heart Failure and Reduced Ejection Fraction;The Journal for Nurse Practitioners;2024-07